Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report)’s stock price rose 4.1% during mid-day trading on Thursday . The stock traded as high as $5.74 and last traded at $5.62. Approximately 32,477 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 708,041 shares. The stock had previously closed at $5.40.
Baird Medical Investment Stock Performance
The business has a 50-day simple moving average of $6.04.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Baird Medical Investment stock. Geode Capital Management LLC bought a new position in Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 10,838 shares of the company’s stock, valued at approximately $82,000. Geode Capital Management LLC owned approximately 0.16% of Baird Medical Investment as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 19.78% of the company’s stock.
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
See Also
- Five stocks we like better than Baird Medical Investment
- What is Short Interest? How to Use It
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What is the S&P 500 and How It is Distinct from Other Indexes
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Quiet Period Expirations Explained
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.